๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Maintenance Therapy
Clinical trial register · China

Maintenance Therapy Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 3 Suzhou 3 Shanghai 3 Nanjing 1 Beijing 1
Narrow the registerReset
Recruitment status
Phase
Site location
Guangzhou3 Suzhou3 Shanghai3 Nanjing1 Beijing1
All 8 locations
Target enrolment
to

Maintenance Therapy trials in China

11 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
Chidamide in HR-AML
NCT07822789Acute Myeloid Leukemia, Maintenance Therapy
Guangdong Second Provincial General Hospital
Observational
33
Guangzhou
2026-07-27
Recruiting
MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib
NCT07463651Acute Myeloid Leukemia (AML), FLT3-ITD Mutation, Allogeneic Hematopoietic Cell Transplantation (HCT), Maintenance Therapy
The First Affiliated Hospital of Soochow University
Phase 3
594
Suzhou, Shanghai
2026-05-01
Recruiting
A Real-world Study on the Efficacy and Safety of Menin Inhibitors as Maintenance After Allo-HSCT
NCT07559695Menin Inhibitors, Acute Leukemia, Post Hematopoietic Stem Cell Transplantation, Maintenance Therapy
The First Affiliated Hospital of Soochow University
Observational
20
Suzhou
2025-11-01
Recruiting
Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia
NCT07101497Menin Inhibitors, Post Hematopoietic Stem Cell Transplantation, Maintenance Therapy, Acute Leukemia
DrugBN104
The First Affiliated Hospital of Soochow University
Phase 2
60
Suzhou
2025-08-01
Not yet open
Maintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected Pancreatic Cancer With High Risk of Recurrence/Metastasis
NCT06779318Pancreatic Cancer, Postoperative Adjuvant Therapy, Maintenance Therapy
The First Affiliated Hospital with Nanjing Medical University
Phase 4
464
Nanjing
2025-07
Not yet open
Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer
NCT06888037Gastric Adenocarcinoma, GEJ Adenocarcinoma, First-line Therapy, Maintenance Therapy
Ruijin Hospital
Phase 2
55
Shanghai
2025-03-31
Recruiting
Efficacy and Safety of Autologous Peptide-induced Active Immunity in AML Maintenance Therapy
NCT07551037Acute Myeloid Leukemia, Personalized Active Immunotherapy, Maintenance Therapy
Fujian Medical University Union Hospital
Phase 1
90
Fuzhou
2024-09-01
Recruiting
A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma
NCT06341556Mantle Cell Lymphoma, Maintenance Therapy
Fudan University
Phase 2
52
Shanghai
2024-05-24
Recruiting
Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma
NCT06277050Nasopharyngeal Carcinoma, High-Risk Cancer, Maintenance Therapy
Jiangxi Provincial Cancer Hospital
Phase 3
264
Ganzhou, Guangzhou, Nanchang
2024-03-07
Active, closed
Maintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal Carcinoma
NCT05869227Nasopharyngeal Carcinoma, Maintenance Therapy
XIANG YANQUN
Phase 3
166
Guangzhou
2023-04-28
Recruiting
Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)
NCT05965284ANCA-associated Vasculitis, Maintenance Therapy
Chinese SLE Treatment And Research Group
Phase 4
40
Beijing
2023-03-09
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/maintenance-therapy

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies listing the condition Maintenance Therapy.

How many Maintenance Therapy trials are recruiting in China?

7 of the 11 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 2 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Maintenance Therapy), 11 studies
PhaseStudiesRecruitingShare
Phase 23227.3%
Phase 33227.3%
Observational2118.2%
Phase 42118.2%
Phase 1119.1%

Most active sponsors

Lead sponsors with the most studies (Maintenance Therapy)
Lead sponsorStudiesRecruiting
The First Affiliated Hospital of Soochow University33
Chinese SLE Treatment And Research Group11
Fudan University11
Fujian Medical University Union Hospital11
Guangdong Second Provincial General Hospital10
Jiangxi Provincial Cancer Hospital11
Ruijin Hospital10
The First Affiliated Hospital with Nanjing Medical University10
XIANG YANQUN10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.